The U.S. Food and Drug Administration has recorded an Abbreviated New Drug Application (ANDA) identified as ANDA070169 for a Tolazamide product. The product is an oral tablet containing 500 mg of Tolazamide, assigned product number 001. The sponsor listed is USL Pharma. The filing indicates that the product is not a reference drug, does not use a reference standard, and its marketing status is currently marked as discontinued.
Actualités réglementaires17 sept. 2026•3 min de lecture
FDA Lists Tolazamide 500 mg Oral Tablet (ANDA070169) – Discontinued
The FDA’s ANDA070169 filing for Tolazamide 500 mg oral tablets by USL Pharma is marked as discontinued.
Compilé par l'équipe Pharmacountry · Source : FDA.gov
Sujets :
Évaluations
(0)
(0)
(0)
(0)
(0)
Laissez votre note